Skip to content

Clinical trials

Terminated Phase 2 Anemia, Refractory trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Refractory Phase: Phase 2 Status: Terminated Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20051
20062
20091
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center2
Wake Forest University Health Sciences2
Alison Walker1
CTI BioPharma1
H. Lee Moffitt Cancer Center and Research Institute1
OHSU Knight Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Refractory8
Anemia, Refractory, with Excess of Blasts8
Myelodysplastic Syndromes8
Leukemia7
Leukemia, Myelomonocytic, Chronic7
Leukemia, Myeloid, Acute4
Myelodysplastic-Myeloproliferative Diseases4
Myeloproliferative Disorders4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Leukemia, Lymphocytic, Chronic, B-Cell3

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.